Obexelimab API Manufacturers
compare suppliers & get competitive offers
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Obexelimab is listed?
Join our notification list by following this page.
Join our notification list by following this page.
List your company
Are you a supplier of Obexelimab or other APIs and are you looking to list your company on Pharmaoffer?
Click the button below to find out more
Click the button below to find out more
Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?
Click the button below to switch over to the contract services area of Pharmaoffer.
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Obexelimab API 1690307-05-1?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Obexelimab. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Obexelimab
- Synonyms:
- AMG 729 , humanized anti-CD19, Fc engineered, monoclonal antibody with enhanced binding to FcyRIIb , Immunoglobulin G1, anti-(human CD19 antigen) (human-mus musculus monoclonal XMAB5871 heavy chain), disulfide with human-mus musculus monoclonal XMAB5871 light chain, dimer , XMAB5871 (HUMANIZED ANTI-CD19 ANTIBODY WITH AN FC PORTION ENGINEERED FOR INCREASED AFFINITY (200- TO 400-FOLD OVER NATIVE IGG) TO FCGRIIB)
- Cas Number:
- 1690307-05-1
- DrugBank number:
- DB15032
- Unique Ingredient Identifier:
- RM16A4BA8R
General Description:
Obexelimab, identified by CAS number 1690307-05-1, is a notable compound with significant therapeutic applications. Obexelimab is under investigation in clinical trial NCT02725515 (A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus).
